保健技术公司优化Rx报告Q4收入增长强劲,预计2025年为100万美元。 Healthcare tech firm OptimizeRx reports strong Q4 revenue growth, projecting $100M for 2025.

医疗保健技术公司 " 优化Rx " 报告说,Q4成果强劲,收入增长14%,达到3 230万美元,全年增长29%,达到9 210万美元。 Healthcare tech firm OptimizeRx reported strong Q4 results with a 14% revenue increase to $32.3 million and 29% full-year growth to $92.1 million. 尽管该年公认会计原则净亏损2 010万美元,但该公司的Q4毛利润增加了23%,达到2 200万美元。 Despite a GAAP net loss of $20.1 million for the year, the company saw a 23% Q4 gross profit rise to $22.0 million. 2025年,优化Rx项目预计收入至少为1亿美元,调整后的EBITDA为1 200万美元。 For 2025, OptimizeRx projects at least $100 million in revenue and $12 million in Adjusted EBITDA. 报告之后的星期三,库存猛增了37%。 The stock surged 37% on Wednesday after the report.